February 2026

Pharmactive Biotech Products > Blog > 2026 > February

Affron® becomes first saffron extract to obtain MFDS Individual Approval for Stress Relief in South Korea

Pharmactive February 11, 2026 11:16 amFebruary 11, 20260 Comments

MFDS Approval Saffron Extract: Affron® Achieves Regulatory Milestone in South Korea Affron®, Pharmactive’s standardized saffron extract, has officially obtained MFDS

Avda. del Doctor Severo Ochoa, 37, Local 4J.
Alcobendas, Madrid (Spain).
CP: 28100
Tel: +34 91 112 38 48
Email: info@pharmactive.eu

PREMIUM Ingredients

Affron^®
Abg+^®
Plasys300^®
Isenolic^®
Olivactive^®

Affroneye^®
Csat+^®
Liboost^®
Kwd+^®
Xorialyc^®

INFORMATION

Blog
Contact
Newsroom
Who We Are
Quality
Events
Work with Us

Subscribe to Our Newsletter

I accept the Terms of Use and the Pharmactive Privacy Policy.

The latest news delivered directly to your inbox! Your information is confidential and we will not send spam.

Legal Notice · Cookie Policy · Privacy Policy · Login

Home
Ingredients
Quality
Blog
Newsroom
Who We Are
Events
Work with Us
- Our Job Offers
Contact

USA Website

Main Website

This website´s content is dedicated to Food Supplements and Pharmaceutical Industry professionals only. It is not aimed at the general public or healthcare professionals.

Please, indicate your regional area before entering:

The statements on this site have not been evaluated by the Food and Drug Administration, or the European Food Safety Authority (EFSA). The products presented are not intended to diagnose, treat, cure or prevent any disease.